These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17437730)

  • 1. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.
    Valgimigli M; Serruys PW; Tsuchida K; Vaina S; Morel MA; van den Brand MJ; Colombo A; Morice MC; Dawkins K; de Bruyne B; Kornowski R; de Servi S; Guagliumi G; Jukema JW; Mohr FW; Kappetein AP; Wittebols K; Stoll HP; Boersma E; Parrinello G;
    Am J Cardiol; 2007 Apr; 99(8):1072-81. PubMed ID: 17437730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntax score predicts clinical outcome in patients with three-vessel coronary artery disease undergoing percutaneous coronary intervention.
    He JQ; Gao YC; Yu XP; Zhang XL; Luo YW; Wu CY; Li Y; Zhang WD; Chen F; Lü SZ
    Chin Med J (Engl); 2011 Mar; 124(5):704-9. PubMed ID: 21518562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of coronary vasculature predicts outcome of surgery for left main disease.
    Birim O; van Gameren M; Bogers AJ; Serruys PW; Mohr FW; Kappetein AP
    Ann Thorac Surg; 2009 Apr; 87(4):1097-104; discussion 1104-5. PubMed ID: 19324134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
    Brener SJ; Milford-Beland S; Roe MT; Bhatt DL; Weintraub WS; Brindis RG;
    Am Heart J; 2008 Jan; 155(1):140-6. PubMed ID: 18082505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SYNTAX Score is associated with worse outcomes after off-pump coronary artery bypass grafting surgery for three-vessel or left main complex coronary disease.
    Carnero-Alcázar M; Maroto Castellanos LC; Silva Guisasola JA; Cobiella Carnicer J; Alswies A; Fuentes Ferrer ME; Rodríguez Hernández JE
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):e123-32. PubMed ID: 21269648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The classification of coronary lesion from Society for Cardiac Angiography and Intervention predicts better results of coronary angioplasty than the one from American College of Cardiology/American Heart Association Coronary Disease].
    Dussaillant GR; Cumsille F; Ramírez A; Pacheco C; Ugalde H; Oyonarte M;
    Rev Med Chil; 2001 Jun; 129(6):605-10. PubMed ID: 11510199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C; Angiolillo DJ; Capranzano P; Dimopoulos K; La Manna A; Barbagallo R; Tagliareni F; Mangiafico S; Guzman LA; Galassi AR; Bass TA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):448-56. PubMed ID: 18814218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.
    Madan P; Elayda MA; Lee VV; Wilson JM
    Am Heart J; 2008 Jun; 155(6):1068-74. PubMed ID: 18513521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
    Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
    Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
    Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.